MedPacto, Inc.   Report issue

For profit Phase 2
Founded: Suwon Korea, Republic of (2013)

Organization Overview

First Clinical Trial
2014
NCT02160106
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

MedPacto, Inc.